Submit Deal

Christopher D. Comeau

Partner at Ropes & Gray

Lawyer

Boston

Deal Bio

Total Deals24

Valued Deals13

Total Value£26,938M

Avg. Deal Size£2,072M

Market Context

Awards

2022 Top FinTech Lawyers in North America

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

Expertise

Key Relationships (24)

Sort

United States

Pharmaceuticals

PublicMergerAcquisition

target

Tesaro

bidder

Glaxosmithkline

£3,371m

41 dealmakers

United States

Digital Services

PrivatePrivate EquityAcquisitionMinorityPrivate Equity

target

NETDOCUMENTS

bidder

Cove Hill Partners

value n/a

15 dealmakers

United States

Clothing and Accessories

MajorityAcquisitionPrivatePrivate EquityCross Border

target

Prive Revaux

bidder

Safilo Group

£52m

22 dealmakers

United States

Health Care Services

PrivateAcquisitionPrivate EquityMajorityDomestic

target

Pathway Vet Alliance

bidder

Tsg Consumer Partners

value n/a

56 dealmakers

United States

Recreational Products

PrivateAcquisitionPrivate EquityMajorityDomesticDisposal

target

Radio Systems Corporation

bidder

Clayton Dubilier & Rice

value n/a

43 dealmakers

United States

Medical Equipment

AcquisitionPrivateMajority

target

Titan Spine

bidder

Medtronic

value n/a

14 dealmakers

United States

Biotechnology

DomesticAcquisitionMajorityPublic

target

Akcea Therapeutics

bidder

Ionis Pharmaceuticals

£334m

36 dealmakers

United States

Biotechnology

MajorityAcquisitionDomesticPrivate EquityPublic

target

Prevail Therapeutics

bidder

Eli Lilly And Company

£778m

36 dealmakers

United States

Tires

Private EquityAcquisitionMajorityPrivateDomestic

target

Mavis Tire Express Services Corp

bidder

Tsg Consumer Partners

£4,304m

80 dealmakers

United States

Household Furnishings

PrivateMinorityPrivate EquityDomesticAcquisition

target

Walker Edison

bidder

Blackstone Tactical Opportunities

£213m

40 dealmakers

United StatesUnited States

Medical Equipment

AcquisitionCross BorderPublicMajority

target

Intersect Ent

bidder

Medtronic

£790m

43 dealmakers

United States

Biotechnology

DomesticMajorityAcquisitionPublic

target

Acceleron Pharma

bidder

Merck & Co

£8,528m

80 dealmakers

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy